Qube Research & Technologies (QRT)
EFTR

Qube Research & Technologies (QRT)’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$1 – 4369
2024
Q2 		$1 Hold
3
– – ﹤0.01% 3718
2024
Q1 		$43 Hold
3
– – ﹤0.01% 4223
2023
Q4 		$38 Buy
+3
New +$40 ﹤0.01% 4094

Other funds holding EFTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EFTR Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2024, closing a stake of 3 shares — an estimated $1 sold.

Qube Research & Technologies (QRT) first reported a position in EFTR in Q4 2023 and held it in 3 quarters. The position peaked at $43 in Q1 2024. 3 funds tracked by Wall St. Rank hold EFTR as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $1.
  • Qube Research & Technologies (QRT) first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s eFFECTOR Therapeutics, Inc. Common Stock position peaked at $43 in Q1 2024.
  • 3 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.